|
HRTX Heron Therapeutics Inc de 818033 |
| Balance Sheet |
|
Current Assets
|
209,014,000 |
|
Assets
|
233,147,000 |
|
Current Liabilities
|
91,457,000 |
|
Liabilities
|
266,798,000 |
|
Equity
|
-33,651,000 |
|
Shares Out
|
151,668,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-22,529,000 |
|
Investing Cash Flow
|
18,714,000 |
| Market Analysis |
Market Cap
|
288,927,535 |
|
Price
|
2.39 |
|
BVPS
|
0.70 |
|
PB
|
3.45 |
|
EPS
|
-0.32 |
|
PS
|
0.50 |
|
FCF
|
-3,815,000 |
|
| Earnings |
|
| Jan |
Feb |
Mar |
|
|
2/27 |
-0.09 |
3/12 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view HRTX documents filed with the SEC.
HRTX Filings
Clear
